> 0 1 0 1 O
200 2 5 2 5 B-lower_bound
mg 6 8 6 8 I-lower_bound
of 9 11 9 11 O
monoclonal 12 22 12 22 B-chronic_disease
protein 23 30 23 30 I-chronic_disease
in 31 33 31 33 O
the 34 37 34 37 O
urine 38 43 38 43 O
on 44 46 44 46 O
screening 47 56 47 56 O
24 57 59 57 59 O
- 59 60 59 60 O
hour 60 64 60 64 O
electrophoresis 65 80 65 80 B-clinical_variable

A 0 1 81 82 O
female 2 8 83 89 B-gender
of 9 11 90 92 O
childbearing 12 24 93 105 O
potential 25 34 106 115 O
( 35 36 116 117 O
FCBP 36 40 117 121 O
) 40 41 121 122 O
is 42 44 123 125 O
a 45 46 126 127 O
sexually 47 55 128 136 O
mature 56 62 137 143 O
woman 63 68 144 149 B-gender
who 69 72 150 153 O
: 72 73 153 154 O
1 74 75 155 156 O
) 75 76 156 157 O
has 77 80 158 161 O
not 81 84 162 165 O
undergone 85 94 166 175 O
a 95 96 176 177 O
hysterectomy 97 109 178 190 B-treatment
or 110 112 191 193 O
bilateral 113 122 194 203 B-treatment
oophorectomy 123 135 204 216 I-treatment
; 135 136 216 217 O
or 137 139 218 220 O
2 140 141 221 222 O
) 141 142 222 223 O
has 143 146 224 227 O
not 147 150 228 231 O
been 151 155 232 236 O
naturally 156 165 237 246 O
postmenopausal 166 180 247 261 O
for 181 184 262 265 O
at 185 187 266 268 O
least 188 193 269 274 O
24 194 196 275 277 O
consecutive 197 208 278 289 O
months 209 215 290 296 O
( 216 217 297 298 O
i.e. 217 221 298 302 O
, 221 222 302 303 O
has 223 226 304 307 O
had 227 230 308 311 O
menses 231 237 312 318 O
at 238 240 319 321 O
any 241 244 322 325 O
time 245 249 326 330 O
in 250 252 331 333 O
the 253 256 334 337 O
preceding 257 266 338 347 O
24 267 269 348 350 O
consecutive 270 281 351 362 O
months 282 288 363 369 O
) 288 289 369 370 O

Absolute 0 8 371 379 B-language_fluency
neutrophil 9 19 380 390 I-language_fluency
count 20 25 391 396 I-language_fluency
( 26 27 397 398 I-language_fluency
ANC 27 30 398 401 I-language_fluency
) 30 31 401 402 I-language_fluency
> 32 33 403 404 O
= 33 34 404 405 O
1000 35 39 406 410 B-lower_bound
/ 39 40 410 411 I-lower_bound
uL 40 42 411 413 I-lower_bound

Anemia 0 6 414 420 B-chronic_disease
> 7 8 421 422 O
2 9 10 423 424 B-lower_bound
g 11 12 425 426 I-lower_bound
/ 12 13 426 427 I-lower_bound
dL 13 15 427 429 I-lower_bound
below 16 21 430 435 O
the 22 25 436 439 O
lower 26 31 440 445 O
limit 32 37 446 451 O
of 38 40 452 454 O
normal 41 47 455 461 O
or 48 50 462 464 O
a 51 52 465 466 O
hemoglobin 53 63 467 477 B-clinical_variable
value 64 69 478 483 I-clinical_variable
< 70 71 484 485 O
10 72 74 486 488 B-upper_bound
g 75 76 489 490 I-upper_bound
/ 76 77 490 491 I-upper_bound
dL 77 79 491 493 I-upper_bound

Aspartate 0 9 494 503 B-clinical_variable
aminotransferase 10 26 504 520 I-clinical_variable
( 27 28 521 522 I-clinical_variable
AST 28 31 522 525 I-clinical_variable
) 31 32 525 526 I-clinical_variable
and 33 36 527 530 O
alanine 37 44 531 538 B-clinical_variable
aminotransferase 45 61 539 555 I-clinical_variable
( 62 63 556 557 I-clinical_variable
ALT 63 66 557 560 I-clinical_variable
) 66 67 560 561 I-clinical_variable
< 68 69 562 563 O
3 70 71 564 565 B-upper_bound
x 72 73 566 567 I-upper_bound
the 74 77 568 571 I-upper_bound
institutional 78 91 572 585 I-upper_bound
upper 92 97 586 591 I-upper_bound
limit 98 103 592 597 I-upper_bound
of 104 106 598 600 I-upper_bound
normal 107 113 601 607 I-upper_bound

Bone 0 4 608 612 B-chronic_disease
lesions 5 12 613 620 I-chronic_disease
: 12 13 620 621 O
lytic 14 19 622 627 B-chronic_disease
lesions 20 27 628 635 I-chronic_disease
, 27 28 635 636 O
severe 29 35 637 643 O
osteopenia 36 46 644 654 B-chronic_disease
or 47 49 655 657 O
pathologic 50 60 658 668 B-chronic_disease
fractures 61 70 669 678 I-chronic_disease

Both 0 4 679 683 O
men 5 8 684 687 B-gender
and 9 12 688 691 I-gender
women 13 18 692 697 I-gender
of 19 21 698 700 O
all 22 25 701 704 O
races 26 31 705 710 O
and 32 35 711 714 O
ethnic 36 42 715 721 O
groups 43 49 722 728 O
are 50 53 729 732 O
eligible 54 62 733 741 O
for 63 66 742 745 O
this 67 71 746 750 O
study 72 77 751 756 O

Eastern 0 7 757 764 B-clinical_variable
Cooperative 8 19 765 776 I-clinical_variable
Oncology 20 28 777 785 I-clinical_variable
Group 29 34 786 791 I-clinical_variable
( 35 36 792 793 I-clinical_variable
ECOG 36 40 793 797 I-clinical_variable
) 40 41 797 798 I-clinical_variable
performance 42 53 799 810 I-clinical_variable
status 54 60 811 817 I-clinical_variable
= 61 62 818 819 O
< 62 63 819 820 O
2 64 65 821 822 B-upper_bound
( 66 67 823 824 O
Karnofsky 67 76 824 833 B-clinical_variable
> 77 78 834 835 O
= 78 79 835 836 O
60 80 82 837 839 B-lower_bound
% 82 83 839 840 I-lower_bound
) 83 84 840 841 O
is 85 87 842 844 O
required 88 96 845 853 O
for 97 100 854 857 O
eligibility 101 112 858 869 O
; 112 113 869 870 O
those 114 119 871 876 O
patients 120 128 877 885 O
with 129 133 886 890 O
lower 134 139 891 896 O
performance 140 151 897 908 O
status 152 158 909 915 O
based 159 164 916 921 O
solely 165 171 922 928 O
on 172 174 929 931 O
bone 175 179 932 936 O
pain 180 184 937 941 O
secondary 185 194 942 951 O
to 195 197 952 954 O
multiple 198 206 955 963 B-cancer
myeloma 207 214 964 971 I-cancer

Evidence 0 8 972 980 O
of 9 11 981 983 O
any 12 15 984 987 O
end 16 19 988 991 O
organ 20 25 992 997 O
damage 26 32 998 1004 O
criteria 33 41 1005 1013 O
listed 42 48 1014 1020 O
below 49 54 1021 1026 O
( 55 56 1027 1028 O
at 56 58 1028 1030 O
any 59 62 1031 1034 O
time 63 67 1035 1039 O
) 67 68 1039 1040 O
attributed 69 79 1041 1051 O
to 80 82 1052 1054 O
the 83 86 1055 1058 O
patient 87 94 1059 1066 O
's 94 96 1066 1068 O
myeloma 97 104 1069 1076 B-cancer

Females 0 7 1077 1084 B-gender
of 8 10 1085 1087 O
childbearing 11 23 1088 1100 O
potential 24 33 1101 1110 O
( 34 35 1111 1112 O
FCBP 35 39 1112 1116 O
) 39 40 1116 1117 O
must 41 45 1118 1122 O
have 46 50 1123 1127 O
a 51 52 1128 1129 O
negative 53 61 1130 1138 B-pregnancy
serum 62 67 1139 1144 I-pregnancy
or 68 70 1145 1147 O
urine 71 76 1148 1153 B-pregnancy
pregnancy 77 86 1154 1163 I-pregnancy
test 87 91 1164 1168 O
with 92 96 1169 1173 O
a 97 98 1174 1175 O
sensitivity 99 110 1176 1187 O
of 111 113 1188 1190 O
at 114 116 1191 1193 O
least 117 122 1194 1199 O
50 123 125 1200 1202 B-lower_bound
mIU 126 129 1203 1206 I-lower_bound
/ 129 130 1206 1207 I-lower_bound
mL 130 132 1207 1209 I-lower_bound
prior 133 138 1210 1215 B-treatment
to 139 141 1216 1218 I-treatment
starting 142 150 1219 1227 I-treatment
therapy 151 158 1228 1235 I-treatment
and 159 162 1236 1239 O
prior 163 168 1240 1245 O
to 169 171 1246 1248 O
beginning 172 181 1249 1258 O
another 182 189 1259 1266 O
cycle 190 195 1267 1272 O

Hypercalcemia 0 13 1273 1286 B-chronic_disease
: 13 14 1286 1287 O
serum 15 20 1288 1293 B-clinical_variable
calcium 21 28 1294 1301 I-clinical_variable
> 29 30 1302 1303 O
11.5 31 35 1304 1308 B-lower_bound
mg 36 38 1309 1311 I-lower_bound
/ 38 39 1311 1312 I-lower_bound
dL 39 41 1312 1314 I-lower_bound

Patient 0 7 1315 1322 O
must 8 12 1323 1327 O
have 13 17 1328 1332 O
relapsed 18 26 1333 1341 O
or 27 29 1342 1344 O
refractory 30 40 1345 1355 O
myeloma 41 48 1356 1363 B-cancer
that 49 53 1364 1368 O
fits 54 58 1369 1373 O
or 59 61 1374 1376 O
did 62 65 1377 1380 O
fit 66 69 1381 1384 O
International 70 83 1385 1398 O
Myeloma 84 91 1399 1406 O
Working 92 99 1407 1414 O
Group 100 105 1415 1420 O
( 106 107 1421 1422 O
IMWG 107 111 1422 1426 O
) 111 112 1426 1427 O
diagnostic 113 123 1428 1438 O
criteria 124 132 1439 1447 O
for 133 136 1448 1451 O
symptomatic 137 148 1452 1463 B-cancer
myeloma 149 156 1464 1471 I-cancer

Patients 0 8 1472 1480 O
must 9 13 1481 1485 O
agree 14 19 1486 1491 O
not 20 23 1492 1495 O
to 24 26 1496 1498 O
donate 27 33 1499 1505 O
blood 34 39 1506 1511 O
, 39 40 1511 1512 O
sperm 41 46 1513 1518 O
/ 46 47 1518 1519 O
ova 47 50 1519 1522 O
during 51 57 1523 1529 O
the 58 61 1530 1533 O
course 62 68 1534 1540 O
of 69 71 1541 1543 O
taking 72 78 1544 1550 O
protocol 79 87 1551 1559 O
therapy 88 95 1560 1567 B-treatment
and 96 99 1568 1571 O
for 100 103 1572 1575 O
at 104 106 1576 1578 O
least 107 112 1579 1584 O
4 113 114 1585 1586 B-lower_bound
weeks 115 120 1587 1592 I-lower_bound
after 121 126 1593 1598 I-lower_bound
stopping 127 135 1599 1607 O
treatment 136 145 1608 1617 B-treatment

Patients 0 8 1618 1626 O
must 9 13 1627 1631 O
be 14 16 1632 1634 O
able 17 21 1635 1639 O
to 22 24 1640 1642 O
avoid 25 30 1643 1648 O
direct 31 37 1649 1655 O
contact 38 45 1656 1663 O
with 46 50 1664 1668 O
pregnant 51 59 1669 1677 B-pregnancy
or 60 62 1678 1680 O
nursing 63 70 1681 1688 O
women 71 76 1689 1694 B-gender
, 76 77 1694 1695 O
infants 78 85 1696 1703 O
and 86 89 1704 1707 O
immunocompromised 90 107 1708 1725 O
individuals 108 119 1726 1737 O
during 120 126 1738 1744 O
the 127 130 1745 1748 O
days 131 135 1749 1753 O
of 136 138 1754 1756 O
reolysin 139 147 1757 1765 B-treatment
treatment 148 157 1766 1775 I-treatment
and 158 161 1776 1779 O
for 162 165 1780 1783 O
two 166 169 1784 1787 B-upper_bound
days 170 174 1788 1792 I-upper_bound
after 175 180 1793 1798 I-upper_bound

Patients 0 8 1799 1807 O
must 9 13 1808 1812 O
have 14 18 1813 1817 O
been 19 23 1818 1822 O
previously 24 34 1823 1833 O
treated 35 42 1834 1841 O
with 43 47 1842 1846 O
an 48 50 1847 1849 O
immunomodulatory 51 67 1850 1866 B-treatment
drug 68 72 1867 1871 I-treatment
( 73 74 1872 1873 I-treatment
IMiD 74 78 1873 1877 I-treatment
) 78 79 1877 1878 I-treatment
and 80 83 1879 1882 O
proteasome 84 94 1883 1893 B-treatment
inhibitor 95 104 1894 1903 I-treatment
, 104 105 1903 1904 O
must 106 110 1905 1909 O
be 111 113 1910 1912 O
refractory 114 124 1913 1923 O
to 125 127 1924 1926 O
carfilzomib 128 139 1927 1938 B-treatment
defined 140 147 1939 1946 O
as 148 150 1947 1949 O
progression 151 162 1950 1961 O
on 163 165 1962 1964 O
or 166 168 1965 1967 O
within 169 175 1968 1974 O
2 176 177 1975 1976 B-upper_bound
months 178 184 1977 1983 I-upper_bound
of 185 187 1984 1986 O
a 188 189 1987 1988 O
carfilzomib 190 201 1989 2000 B-treatment
- 201 202 2000 2001 I-treatment
containing 202 212 2001 2011 I-treatment
therapy 213 220 2012 2019 I-treatment
, 220 221 2019 2020 O
and 222 225 2021 2024 O
must 226 230 2025 2029 O
be 231 233 2030 2032 O
progressing 234 245 2033 2044 O

Patients 0 8 2045 2053 O
must 9 13 2054 2058 O
not 14 17 2059 2062 O
have 18 22 2063 2067 O
known 23 28 2068 2073 O
human 29 34 2074 2079 B-chronic_disease
immunodeficiency 35 51 2080 2096 I-chronic_disease
virus 52 57 2097 2102 I-chronic_disease
( 58 59 2103 2104 I-chronic_disease
HIV 59 62 2104 2107 I-chronic_disease
) 62 63 2107 2108 I-chronic_disease
infection 64 73 2109 2118 O
or 74 76 2119 2121 O
active 77 83 2122 2128 O
hepatitis 84 93 2129 2138 B-chronic_disease
B 94 95 2139 2140 I-chronic_disease
or 96 98 2141 2143 O
C 99 100 2144 2145 B-chronic_disease
infections 101 111 2146 2156 O

Patients 0 8 2157 2165 O
previously 9 19 2166 2176 O
treated 20 27 2177 2184 O
on 28 30 2185 2187 O
clinical 31 39 2188 2196 B-treatment
trial 40 45 2197 2202 I-treatment
with 46 50 2203 2207 I-treatment
reolysin 51 59 2208 2216 I-treatment

Patients 0 8 2217 2225 O
who 9 12 2226 2229 O
are 13 16 2230 2233 O
receiving 17 26 2234 2243 O
any 27 30 2244 2247 O
other 31 36 2248 2253 B-treatment
therapeutic 37 48 2254 2265 I-treatment
investigational 49 64 2266 2281 I-treatment
agents 65 71 2282 2288 I-treatment

Patients 0 8 2289 2297 O
who 9 12 2298 2301 O
have 13 17 2302 2306 O
had 18 21 2307 2310 O
chemotherapy 22 34 2311 2323 B-treatment
or 35 37 2324 2326 O
radiotherapy 38 50 2327 2339 B-treatment
within 51 57 2340 2346 O
2 58 59 2347 2348 B-upper_bound
weeks 60 65 2349 2354 I-upper_bound
prior 66 71 2355 2360 I-upper_bound
to 72 74 2361 2363 O
entering 75 83 2364 2372 O
the 84 87 2373 2376 O
study 88 93 2377 2382 O

Patients 0 8 2383 2391 O
with 9 13 2392 2396 O
a 14 15 2397 2398 O
currently 16 25 2399 2408 O
active 26 32 2409 2415 B-cancer
second 33 39 2416 2422 I-cancer
malignancy 40 50 2423 2433 I-cancer
that 51 55 2434 2438 O
, 55 56 2438 2439 O
in 57 59 2440 2442 O
the 60 63 2443 2446 O
opinion 64 71 2447 2454 O
of 72 74 2455 2457 O
the 75 78 2458 2461 O
principal 79 88 2462 2471 O
investigator 89 101 2472 2484 O
, 101 102 2484 2485 O
will 103 107 2486 2490 O
interfere 108 117 2491 2500 O
with 118 122 2501 2505 O
patient 123 130 2506 2513 O
participation 131 144 2514 2527 O
, 144 145 2527 2528 O
increase 146 154 2529 2537 O
patient 155 162 2538 2545 O
risk 163 167 2546 2550 O
, 167 168 2550 2551 O
shorten 169 176 2552 2559 O
survival 177 185 2560 2568 B-clinical_variable
to 186 188 2569 2571 O
< 189 190 2572 2573 O
1 191 192 2574 2575 B-upper_bound
year 193 197 2576 2580 I-upper_bound
, 197 198 2580 2581 O
or 199 201 2582 2584 O
confound 202 210 2585 2593 O
data 211 215 2594 2598 O
interpretation 216 230 2599 2613 O

Plasma 0 6 2614 2620 B-chronic_disease
cell 7 11 2621 2625 I-chronic_disease
dyscrasia 12 21 2626 2635 I-chronic_disease
with 22 26 2636 2640 O
polyneuropathy 27 41 2641 2655 B-chronic_disease
, 41 42 2655 2656 O
organomegaly 43 55 2657 2669 B-chronic_disease
, 55 56 2669 2670 O
endocrinopathy 57 71 2671 2685 B-chronic_disease
, 71 72 2685 2686 O
monoclonal 73 83 2687 2697 B-chronic_disease
protein 84 91 2698 2705 I-chronic_disease
( 92 93 2706 2707 I-chronic_disease
M 93 94 2707 2708 I-chronic_disease
- 94 95 2708 2709 I-chronic_disease
protein 95 102 2709 2716 I-chronic_disease
) 102 103 2716 2717 I-chronic_disease
, 103 104 2717 2718 O
and 105 108 2719 2722 O
skin 109 113 2723 2727 B-chronic_disease
changes 114 121 2728 2735 I-chronic_disease
( 122 123 2736 2737 I-chronic_disease
POEMS 123 128 2737 2742 I-chronic_disease
) 128 129 2742 2743 I-chronic_disease
syndrome 130 138 2744 2752 I-chronic_disease

Platelet 0 8 2753 2761 B-clinical_variable
count 9 14 2762 2767 I-clinical_variable
> 15 16 2768 2769 O
= 16 17 2769 2770 O
75,000 18 24 2771 2777 B-lower_bound
and 25 28 2778 2781 O
transfusion 29 40 2782 2793 B-treatment
independent 41 52 2794 2805 O

Pregnant 0 8 2806 2814 B-pregnancy
women 9 14 2815 2820 B-gender
are 15 18 2821 2824 O
excluded 19 27 2825 2833 O
from 28 32 2834 2838 O
this 33 37 2839 2843 O
study 38 43 2844 2849 O
; 43 44 2849 2850 O
breastfeeding 45 58 2851 2864 O
should 59 65 2865 2871 O
be 66 68 2872 2874 O
discontinued 69 81 2875 2887 O

Presence 0 8 2888 2896 O
of 9 11 2897 2899 O
clonal 12 18 2900 2906 B-cancer
bone 19 23 2907 2911 I-cancer
marrow 24 30 2912 2918 I-cancer
plasma 31 37 2919 2925 I-cancer
cells 38 43 2926 2931 I-cancer

Prior 0 5 2932 2937 O
autologous 6 16 2938 2948 B-treatment
and/or 17 23 2949 2955 I-treatment
allogeneic 24 34 2956 2966 I-treatment
transplant 35 45 2967 2977 I-treatment
is 46 48 2978 2980 O
permitted 49 58 2981 2990 O
although 59 67 2991 2999 O
transplant 68 78 3000 3010 O
must 79 83 3011 3015 O
have 84 88 3016 3020 O
occurred 89 97 3021 3029 O
greater 98 105 3030 3037 O
than 106 110 3038 3042 O
90 111 113 3043 3045 B-lower_bound
days 114 118 3046 3050 I-lower_bound
prior 119 124 3051 3056 I-lower_bound
to 125 127 3057 3059 O
registration 128 140 3060 3072 O

Prior 0 5 3073 3078 B-treatment
radiation 6 15 3079 3088 I-treatment
is 16 18 3089 3091 O
permitted 19 28 3092 3101 O
; 28 29 3101 3102 O
however 30 37 3103 3110 O
, 37 38 3110 3111 O
at 39 41 3112 3114 O
least 42 47 3115 3120 O
2 48 49 3121 3122 B-lower_bound
weeks 50 55 3123 3128 I-lower_bound
must 56 60 3129 3133 O
have 61 65 3134 3138 O
elapsed 66 73 3139 3146 O
since 74 79 3147 3152 O
the 80 83 3153 3156 O
completion 84 94 3157 3167 O
of 95 97 3168 3170 O
prior 98 103 3171 3176 B-treatment
radiation 104 113 3177 3186 I-treatment
therapy 114 121 3187 3194 I-treatment
and 122 125 3195 3198 O
patients 126 134 3199 3207 O
must 135 139 3208 3212 O
have 140 144 3213 3217 O
recovered 145 154 3218 3227 O
from 155 159 3228 3232 O
all 160 163 3233 3236 O
radiation 164 173 3237 3246 O
- 173 174 3246 3247 O
associated 174 184 3247 3257 O
toxicities 185 195 3258 3268 O
to 196 198 3269 3271 O
no 199 201 3272 3274 O
greater 202 209 3275 3282 O
than 210 214 3283 3287 O
grade 215 220 3288 3293 B-upper_bound
1 221 222 3294 3295 I-upper_bound
at 223 225 3296 3298 O
the 226 229 3299 3302 O
time 230 234 3303 3307 O
of 235 237 3308 3310 O
registration 238 250 3311 3323 O

Renal 0 5 3324 3329 B-chronic_disease
insufficiency 6 19 3330 3343 I-chronic_disease
: 19 20 3343 3344 O
serum 21 26 3345 3350 B-clinical_variable
creatinine 27 37 3351 3361 I-clinical_variable
> 38 39 3362 3363 O
2 40 41 3364 3365 B-lower_bound
mg 42 44 3366 3368 I-lower_bound
/ 44 45 3368 3369 I-lower_bound
dL 45 47 3369 3371 I-lower_bound

Serum 0 5 3372 3377 B-clinical_variable
immunoglobulin 6 20 3378 3392 I-clinical_variable
free 21 25 3393 3397 I-clinical_variable
light 26 31 3398 3403 I-clinical_variable
chain 32 37 3404 3409 I-clinical_variable
> 38 39 3410 3411 O
= 39 40 3411 3412 O
100 41 44 3413 3416 B-lower_bound
mg 45 47 3417 3419 I-lower_bound
/ 47 48 3419 3420 I-lower_bound
L 48 49 3420 3421 I-lower_bound
AND 50 53 3422 3425 O
abnormal 54 62 3426 3434 O
serum 63 68 3435 3440 O
immunoglobulin 69 83 3441 3455 O
kappa 84 89 3456 3461 B-clinical_variable
to 90 92 3462 3464 I-clinical_variable
lambda 93 99 3465 3471 I-clinical_variable
free 100 104 3472 3476 I-clinical_variable
light 105 110 3477 3482 I-clinical_variable
chain 111 116 3483 3488 I-clinical_variable
ratio 117 122 3489 3494 I-clinical_variable

Serum 0 5 3495 3500 B-clinical_variable
monoclonal 6 16 3501 3511 I-clinical_variable
protein 17 24 3512 3519 I-clinical_variable
> 25 26 3520 3521 O
= 26 27 3521 3522 O
500 28 31 3523 3526 B-lower_bound
mg 32 34 3527 3529 I-lower_bound
/ 34 35 3529 3530 I-lower_bound
dL 35 37 3530 3532 I-lower_bound
by 38 40 3533 3535 O
protein 41 48 3536 3543 B-treatment
electrophoresis 49 64 3544 3559 I-treatment

Total 0 5 3560 3565 B-clinical_variable
bilirubin 6 15 3566 3575 I-clinical_variable
< 16 17 3576 3577 O
1.5 18 21 3578 3581 B-upper_bound
mg 22 24 3582 3584 I-upper_bound
/ 24 25 3584 3585 I-upper_bound
dL 25 27 3585 3587 I-upper_bound

Uncontrolled 0 12 3588 3600 O
intercurrent 13 25 3601 3613 O
illness 26 33 3614 3621 O
including 34 43 3622 3631 O
, 43 44 3631 3632 O
but 45 48 3633 3636 O
not 49 52 3637 3640 O
limited 53 60 3641 3648 O
to 61 63 3649 3651 O
, 63 64 3651 3652 O
ongoing 65 72 3653 3660 O
or 73 75 3661 3663 O
active 76 82 3664 3670 B-chronic_disease
infection 83 92 3671 3680 I-chronic_disease
, 92 93 3680 3681 O
symptomatic 94 105 3682 3693 O
congestive 106 116 3694 3704 B-chronic_disease
heart 117 122 3705 3710 I-chronic_disease
failure 123 130 3711 3718 I-chronic_disease
, 130 131 3718 3719 O
unstable 132 140 3720 3728 B-chronic_disease
angina 141 147 3729 3735 I-chronic_disease
pectoris 148 156 3736 3744 I-chronic_disease
, 156 157 3744 3745 O
cardiac 158 165 3746 3753 B-chronic_disease
arrhythmia 166 176 3754 3764 I-chronic_disease

Women 0 5 3765 3770 B-gender
of 6 8 3771 3773 O
child 9 14 3774 3779 O
- 14 15 3779 3780 O
bearing 15 22 3780 3787 O
potential 23 32 3788 3797 O
and 33 36 3798 3801 O
men 37 40 3802 3805 O
must 41 45 3806 3810 O
agree 46 51 3811 3816 B-contraception_consent
to 52 54 3817 3819 I-contraception_consent
use 55 58 3820 3823 I-contraception_consent
adequate 59 67 3824 3832 I-contraception_consent
contraception 68 81 3833 3846 I-contraception_consent
( 82 83 3847 3848 O
hormonal 83 91 3848 3856 B-contraception_consent
or 92 94 3857 3859 O
barrier 95 102 3860 3867 B-contraception_consent
method 103 109 3868 3874 I-contraception_consent
of 110 112 3875 3877 I-contraception_consent
birth 113 118 3878 3883 I-contraception_consent
control 119 126 3884 3891 I-contraception_consent
; 126 127 3891 3892 O
abstinence 128 138 3893 3903 B-contraception_consent
) 138 139 3903 3904 O
starting 140 148 3905 3913 O
28 149 151 3914 3916 B-lower_bound
days 152 156 3917 3921 I-lower_bound
prior 157 162 3922 3927 I-lower_bound
to 163 165 3928 3930 O
starting 166 174 3931 3939 O
the 175 178 3940 3943 O
study 179 184 3944 3949 O
until 185 190 3950 3955 O
at 191 193 3956 3958 O
least 194 199 3959 3964 O
90 200 202 3965 3967 B-lower_bound
days 203 207 3968 3972 I-lower_bound
following 208 217 3973 3982 O
discontinuation 218 233 3983 3998 O
of 234 236 3999 4001 O
the 237 240 4002 4005 O
trial 241 246 4006 4011 O
therapy 247 254 4012 4019 B-treatment

myocardial 0 10 4020 4030 B-chronic_disease
infarction 11 21 4031 4041 I-chronic_disease
in 22 24 4042 4044 O
the 25 28 4045 4048 O
preceding 29 38 4049 4058 O
6 39 40 4059 4060 B-upper_bound
months 41 47 4061 4067 I-upper_bound

patients 0 8 4068 4076 O
may 9 12 4077 4080 O
be 13 15 4081 4083 O
receiving 16 25 4084 4093 O
concomitant 26 37 4094 4105 B-treatment
therapy 38 45 4106 4113 I-treatment
with 46 50 4114 4118 I-treatment
bisphosphonates 51 66 4119 4134 I-treatment
and 67 70 4135 4138 I-treatment
low 71 74 4139 4142 I-treatment
dose 75 79 4143 4147 I-treatment
corticosteroids 80 95 4148 4163 I-treatment
( 96 97 4164 4165 O
e.g. 97 101 4165 4169 O
, 101 102 4169 4170 O
prednisone 103 113 4171 4181 B-treatment
up 114 116 4182 4184 O
to 117 119 4185 4187 O
but 120 123 4188 4191 O
no 124 126 4192 4194 O
more 127 131 4195 4199 O
than 132 136 4200 4204 O
10 137 139 4205 4207 B-upper_bound
mg 140 142 4208 4210 I-upper_bound
by 143 145 4211 4213 O
mouth 146 151 4214 4219 O
daily 152 157 4220 4225 O
or 158 160 4226 4228 O
its 161 164 4229 4232 O
equivalent 165 175 4233 4243 O
) 175 176 4243 4244 O
for 177 180 4245 4248 O
symptom 181 188 4249 4256 O
management 189 199 4257 4267 O
and 200 203 4268 4271 O
comorbid 204 212 4272 4280 O
conditions 213 223 4281 4291 O
; 223 224 4291 4292 O
doses 225 230 4293 4298 O
of 231 233 4299 4301 O
corticosteroid 234 248 4302 4316 O
should 249 255 4317 4323 O
be 256 258 4324 4326 O
stable 259 265 4327 4333 O
for 266 269 4334 4337 O
at 270 272 4338 4340 O
least 273 278 4341 4346 O
7 279 280 4347 4348 B-lower_bound
days 281 285 4349 4353 I-lower_bound
prior 286 291 4354 4359 I-lower_bound
to 292 294 4360 4362 O
study 295 300 4363 4368 O
treatment 301 310 4369 4378 B-treatment

psychiatric 0 11 4379 4390 B-chronic_disease
illness 12 19 4391 4398 I-chronic_disease
/ 19 20 4398 4399 O
social 20 26 4399 4405 O
situations 27 37 4406 4416 O
that 38 42 4417 4421 O
would 43 48 4422 4427 O
limit 49 54 4428 4433 O
compliance 55 65 4434 4444 O
with 66 70 4445 4449 O
study 71 76 4450 4455 O
requirements 77 89 4456 4468 O

should 0 6 4469 4475 O
a 7 8 4476 4477 O
woman 9 14 4478 4483 B-gender
become 15 21 4484 4490 B-pregnancy
pregnant 22 30 4491 4499 I-pregnancy
or 31 33 4500 4502 O
suspect 34 41 4503 4510 O
she 42 45 4511 4514 O
is 46 48 4515 4517 O
pregnant 49 57 4518 4526 O
while 58 63 4527 4532 O
she 64 67 4533 4536 O
or 68 70 4537 4539 O
her 71 74 4540 4543 O
partner 75 82 4544 4551 O
is 83 85 4552 4554 O
participating 86 99 4555 4568 O
in 100 102 4569 4571 O
this 103 107 4572 4576 O
study 108 113 4577 4582 O
, 113 114 4582 4583 O
she 115 118 4584 4587 O
should 119 125 4588 4594 O
inform 126 132 4595 4601 O
her 133 136 4602 4605 O
treating 137 145 4606 4614 O
physician 146 155 4615 4624 O
immediately 156 167 4625 4636 O

